ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS

OBJECTIVE: To report the rate of candidate actionable somatic mutations in patients with locally advanced and metastatic gastro-enteropancreatic (GEP) neuroendocrine tumors (NET) and of other genetic alterations that may be associated with tumorigenesis. METHODS: A phase II mutation targeted therapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocr Pract
Main Authors: Tirosh, Amit, Killian, J. Keith, Zhu, Yuelin Jack, Petersen, David, Walling, Jennifer, Mor-Cohen, Ronit, Neychev, Vladimir, Stevenson, Holly, Keutgen, Xavier M., Patel, Dhaval, Nilubol, Naris, Meltzer, Paul, Kebebew, Electron
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8170837/
https://ncbi.nlm.nih.gov/pubmed/30865533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/EP-2018-0603
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados